中枢神经系统固体瘤的CAR T细胞治疗:目前的进展和未来的方向
Yaroslav Kaminskiy1, Vitaly Degtyarev2, Alexey Stepanov3
1Department of Oncology and Pathology, Karolinska Institutet, SciLifeLab, Solna, Sweden.
Frontiers in immunology
|September 2, 2025
概括
在儿童中枢神经系统 (CNS) 瘤治疗方面, CAR T 细胞疗法显得有前途, 本综述探讨了其有效性,安全性以及改善儿童中枢神经系统癌症的挑战.
科学领域:
- 儿童瘤学
- 神经瘤学
- 免疫疗法
背景情况:
- 中枢神经系统 (CNS) 瘤是第二常见的儿童癌症,也是儿童癌症死亡的主要原因.
- 儿童中枢神经系统高风险瘤的预后不佳,需要新的治疗策略.
- CAR T细胞治疗是一种新兴的免疫疗法,在该患者群体中报告了早期的临床反应.
研究的目的:
- 审查儿童中枢神经系统瘤的CAR T细胞治疗的临床疗效和毒性.
- 分析抗原异质性和CAR T细胞治疗临床实施中的挑战.
- 为儿童中枢神经系统恶性瘤提供更广泛的免疫疗法,包括TIL,NK和LAK细胞.
主要方法:
- 对儿童中枢神经系统瘤的CAR T细胞治疗报告的临床试验和文献的综合分析.
- 对CAR T细胞的系统性与局部传递方法的评估.
- 包括其他免疫治疗方法的研究,如瘤透性淋巴细胞 (TIL),NK细胞和淋巴基因激活杀手细胞 (LAK).
主要成果:
- 在儿童中枢神经系统瘤中,CAR T细胞治疗已经显示出早期客观的临床反应.
- 系统和局部传递方法具有不同的毒性特征.
- 在中枢神经系统瘤中,抗原异质性对有效的CAR T细胞向构成重大挑战.
结论:
- 对于高危的儿童中枢神经系统瘤,CAR T细胞疗法是一个有前途的替代方案.
- 解决传递,抗原向和临床实施方面的挑战对于最大限度地发挥治疗潜力至关重要.
- 更广泛的免疫疗法为儿童中枢神经系统恶性瘤提供了全面的策略.
相关概念视频
Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509


